Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis

Stathmin has been investigated to be involved in development and progress of malignant tumors. This study was to clarify the relationship between expression of stathmin and tumors and assess its clinical significance. We identified 25 studies with a total of 3,571 individuals from the electronic bib...

Full description

Saved in:
Bibliographic Details
Published in:Oncotarget 2016-11, Vol.7 (48), p.78994-79007
Main Authors: Biaoxue, Rong, Hua, Liu, Wenlong, Gao, Shuanying, Yang
Format: Article
Language:English
Subjects:
Aged
Female
Gene Expression Regulation, Neoplastic
Humans
Male
Middle Aged
Neoplasm Metastasis
Neoplasm Staging
Neoplasms - metabolism
Neoplasms - pathology
Research Paper
ROC Curve
Stathmin - metabolism
Survival Analysis
Up-Regulation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Stathmin has been investigated to be involved in development and progress of malignant tumors. This study was to clarify the relationship between expression of stathmin and tumors and assess its clinical significance. We identified 25 studies with a total of 3,571 individuals from the electronic bibliographic databases and strictly evaluated the quality and heterogeneity of included studies. We analysed the relationship between expression of stathmin and clinical characteristics by the fixed-effects and random-effects of meta-analysis and constructed a summary receiver-operator characteristic curve to estimate the test characteristics. The results showed that patients with cancer displayed a higher stathmin expression than those of non-cancer individuals (OR, 0.31), and overexpression of stathmin correlated with tumor cell differentiation (OR, 0.73), lymph node invasion (OR, 0.80) and high TNM stage (OR, 0.67). The pooled sensitivity of stathmin for distinguishing malignant tumors was 0.73 and the specificity was 0.77. The maximum balance joint for sensitivity and specificity (the Q-value) was 0.7566 and the area under the curve (AUC) was 0.8234. In conclusion, these results showed that overexpression of stathmin intimately correlated with malignant behavior of tumors, suggesting it could be a risk factor of malignant tumors. Stathmin had great sensitivity and specificity indicated it should be a significant molecular biomarker for malignant tumors.
ISSN:1949-2553
1949-2553
DOI:10.18632/oncotarget.12982